Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
- PMID: 9671307
- DOI: 10.1038/28212
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Abstract
Malignant rhabdoid tumours (MRTs) are extremely aggressive cancers of early childhood. They can occur in various locations, mainly the kidney, brain and soft tissues. Cytogenetic and molecular analyses have shown that the deletion of region 11.2 of the long arm of chromosome 22 (22q11.2) is a recurrent genetic characteristic of MRTs, indicating that this locus may encode a tumour suppressor gene. Here we map the most frequently deleted part of chromosome 22q11.2 from a panel of 13 MRT cell lines. We observed six homozygous deletions that delineate the smallest region of overlap between the cell lines. This region is found in the hSNF5/INI1 gene, which encodes a member of the chromatin-remodelling SWI/SNF multiprotein complexes. We analysed the sequence of hSNF5/INI1 and found frameshift or nonsense mutations of this gene in six other cell lines. These truncating mutations of one allele were associated with the loss of the other allele. Identical alterations were observed in corresponding primary tumour DNAs but not in matched constitutional DNAs, indicating that they had been acquired somatically. The observation of bi-allelic alterations of hSNF5/INI1 in MRTs suggests that loss-of-function mutations of hSNF5/INI1 contribute to oncogenesis.
Similar articles
-
Integrase interactor 1 in health and disease.Curr Protein Pept Sci. 2015;16(6):478-90. doi: 10.2174/1389203716666150316115156. Curr Protein Pept Sci. 2015. PMID: 25772157 Review.
-
Molecular genetics of atypical teratoid/rhabdoid tumor.Neurosurg Focus. 2006 Jan 15;20(1):E11. doi: 10.3171/foc.2006.20.1.12. Neurosurg Focus. 2006. PMID: 16459991 Review.
-
Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.Genes Chromosomes Cancer. 2002 May;34(1):33-41. doi: 10.1002/gcc.10052. Genes Chromosomes Cancer. 2002. PMID: 11921280
-
Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.Hum Mol Genet. 1999 Dec;8(13):2359-68. doi: 10.1093/hmg/8.13.2359. Hum Mol Genet. 1999. PMID: 10556283
-
hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.Cancer Res. 1999 Jul 1;59(13):3152-6. Cancer Res. 1999. PMID: 10397258
Cited by
-
Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers.Nat Commun. 2024 Jun 5;15(1):4770. doi: 10.1038/s41467-024-49063-w. Nat Commun. 2024. PMID: 38839769 Free PMC article.
-
Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.bioRxiv [Preprint]. 2024 May 6:2024.05.03.592420. doi: 10.1101/2024.05.03.592420. bioRxiv. 2024. PMID: 38766189 Free PMC article. Preprint.
-
Functional Classification of Fusion Proteins in Sarcoma.Cancers (Basel). 2024 Mar 29;16(7):1355. doi: 10.3390/cancers16071355. Cancers (Basel). 2024. PMID: 38611033 Free PMC article. Review.
-
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.Nature. 2024 Apr;628(8007):442-449. doi: 10.1038/s41586-024-07250-1. Epub 2024 Mar 27. Nature. 2024. PMID: 38538798
-
Feeder-free differentiation of human iPSCs into natural killer cells with cytotoxic potential against malignant brain rhabdoid tumor cells.Bioact Mater. 2024 Mar 8;36:301-316. doi: 10.1016/j.bioactmat.2024.02.031. eCollection 2024 Jun. Bioact Mater. 2024. PMID: 38496035 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials